Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon

The prevalence of colon-associated diseases has increased significantly over the past several decades, as evidenced by accumulated literature on conditions such as Crohn’s disease, irritable bowel syndrome, colorectal cancer, and ulcerative colitis. Developing therapeutics for these diseases is chal...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakshi, Hamid A., Quinn, Gerry A., Aljabali, Alaa A. A., Hakkim, Faruck L., Farzand, Rabia, Nasef, Mohamed M., Abuglela, Naji, Ansari, Prawej, Mishra, Vijay, Serrano-Aroca, Ángel, Tambuwala, Murtaza M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709317/
https://www.ncbi.nlm.nih.gov/pubmed/34959610
http://dx.doi.org/10.3390/ph14121211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709317/
https://www.ncbi.nlm.nih.gov/pubmed/34959610
http://dx.doi.org/10.3390/ph14121211

Ejemplares similares